Cerebras Systems Inc. Class A Common Stock (CBRS) stock: key figures, P/E, revenue and dividend
Information Technology · Semiconductors · United States · ISIN US15675D1037
Cerebras Systems Inc. Class A Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 290.25 m USD | 509.99 m USD |
| Gross profit | 122.74 m USD | 199.07 m USD |
| Operating income | -101.64 m USD | -145.25 m USD |
| EBIT | -479.68 m USD | 244.88 m USD |
| Net income | -481.60 m USD | 237.83 m USD |
| Diluted EPS – continuing operations | -2.24 USD | 1.10 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cerebras Systems Inc. Class A Common Stock
Cerebras Systems Inc. operates as an artificial intelligence infrastructure company. It designs and manufactures an AI compute platform that comprises of proprietary systems and software that is delivered in racks for deployment in data centers up to supercomputer scale. The company's pioneering wafer-scale engine, a chip encompassing a silicon wafer, designed to enable higher performance and speeds than GPUs for the computational demands of inference, Generative AI, and other AI applications. Its customers include hyperscalers, foundation model labs, AI-native and digital-native businesses, enterprises, and leaders of Sovereign AI initiatives. The company has operations in the United States, Europe, the Middle East, Africa, and internationally. Cerebras Systems Inc. was founded in 2015 and is headquartered in Sunnyvale, California.
More stocks
- Intact Financial Corporation (IFC.TO)
- Huntington Bancshares (HBAN)
- Leonardo SpA (LDO.MI)
- Kyocera Corp (6971.T)
- Daiichi Sankyo Co Ltd (4568.T)
- Imperial Brands PLC (IMB.L)
- DSM-Firmenich AG (DSFIR.AS)
- Svenska Handelsbanken AB (SHB A.ST)
- Raymond James Financial (RJF)
- Ingersoll Rand (IR)
- ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- Wanhua Chemical Group Co Ltd (600309.SS)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.